OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine and Ginsenoside Rb1 Ameliorate Depression-Like Behavior in Diabetic Rats
Jinghua Zhang, Huizeng Yang, Hao Su, et al.
The American Journal of Chinese Medicine (2021) Vol. 49, Iss. 05, pp. 1195-1213
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Antidepressant Potential of Quercetin and its Glycoside Derivatives: A Comprehensive Review and Update
Chen Shen, Yueheng Tang, Yang Gao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50

Gut microbiota-SCFAs-brain axis associated with the antidepressant activity of berberine in CUMS rats
Mengnan Huang, Yuanyuan He, Lin Tian, et al.
Journal of Affective Disorders (2023) Vol. 325, pp. 141-150
Closed Access | Times Cited: 30

The potential role of plant secondary metabolites on antifungal and immunomodulatory effect
Xuedong Zhou, Meng Zeng, Fujiao Huang, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 14, pp. 4471-4492
Open Access | Times Cited: 25

Berberine hydrochloride alleviates imatinib mesylate – induced cardiotoxicity through the inhibition of Nrf2-dependent ferroptosis
Chengzhu Song, Dongning Li, Jie Zhang, et al.
Food & Function (2023) Vol. 14, Iss. 2, pp. 1087-1098
Closed Access | Times Cited: 22

NADPH-oxidases as potential pharmacological targets for thrombosis and depression comorbidity
Patrizia Amadio, Leonardo Sandrini, M Zara, et al.
Redox Biology (2024) Vol. 70, pp. 103060-103060
Open Access | Times Cited: 9

Banxia Xiexin decoction alleviates AS co-depression disease by regulating the gut microbiome-lipid metabolic axis
Xing-Xing Liao, Ke Hu, Xie Xinhua, et al.
Journal of Ethnopharmacology (2023) Vol. 313, pp. 116468-116468
Open Access | Times Cited: 17

Research progress on antidepressant effects and mechanisms of berberine
Yang Gao, Kexin Nie, Hongzhan Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7

The antidepressive mechanism of Longya Lilium combined with Fluoxetine in mice with depression-like behaviors
Huina Ma, Hehua Huang, Chenyu Li, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6

Depression in breast cancer patients: Immunopathogenesis and immunotherapy
Sheng Yu, Wen Li, Lingxue Tang, et al.
Cancer Letters (2022) Vol. 536, pp. 215648-215648
Closed Access | Times Cited: 23

Neurotrophic basis to the pathogenesis of depression and phytotherapy
Huiqin Wang, Yantao Yang, Gang Pei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13

Neuroprotective effect and preparation methods of berberine
Yi-Xuan Sunhe, Yuehui Zhang, Rui‐Jia Fu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5

Berberine: an isoquinoline alkaloid targeting the oxidative stress and gut-brain axis in the models of depression
Cong-Ya Chen, Yi Zhang
European Journal of Medicinal Chemistry (2025), pp. 117475-117475
Closed Access

The possible role of neurogenesis activators in temporal lobe epilepsy: State of art and future perspective
Ahmed Salem Al-Dhahi, Hayder M. Al‐kuraishy, Ali K. Albuhadily, et al.
European Journal of Pharmacology (2025), pp. 177646-177646
Open Access

Several major herb pairs containing Coptidis rhizoma: a review of key traditional uses, constituents and compatibility effects
Shiyu Li, Ding‐Qiao Xu, Yanyan Chen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

Ginsenoside Rb1 improves energy metabolism after spinal cord injury
Xifan Mei, Shan Wen, Zhiru Zou, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 6, pp. 1332-1332
Open Access | Times Cited: 10

Ginsenosides can target brain-derived neurotrophic factor to improve Parkinson's disease
Yingying Ding, Benson O. A. Botchway, Yong Zhang, et al.
Food & Function (2023) Vol. 14, Iss. 12, pp. 5537-5550
Closed Access | Times Cited: 6

Apatinib and Ginsenoside-Rb1 Synergetically Control the Growth of Hypopharyngeal Carcinoma Cells
Yanwei Li, Feng He, Yu Zhang, et al.
Disease Markers (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 9

Antidepressant-Like Effect and Mechanism of Ginsenoside Rd on Rodent Models of Depression
Yu Li, Mei-Ling Wang, Bo Zhang, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 843-861
Open Access | Times Cited: 9

Dapagliflozin improves diabetic cognitive impairment via indirectly modulating the mitochondria homeostasis of hippocampus in diabetic mice
Zichen Gui, Jiawen Wang, Yue Zhang, et al.
BioFactors (2023) Vol. 50, Iss. 1, pp. 145-160
Closed Access | Times Cited: 5

Antidepressant Active Ingredients From Chinese Traditional Herb Panax Notoginseng: A Pharmacological Mechanism Review
Yanwei Li, Qingwan Guo, Junqing Huang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8

Phytochemical interventions for post-traumatic stress disorder: A cluster co-occurrence network analysis using CiteSpace
Biao Gao, Y. Qu, Mengyu Cai, et al.
Journal of Integrative Medicine (2023) Vol. 21, Iss. 4, pp. 385-396
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top